Skip to main content

New and emerging drug therapies for the management of acute heart failure

Buy Article:

$51.00 plus tax (Refund Policy)



In recent times, there have been many developments in therapies for acute heart failure, in contrast to the preceding 20 years. These have been mainly fuelled by new and expanding knowledge about the pathophysiology of heart failure, which has allowed for insight into potential therapeutic strategies. This review will examine the key emerging therapies for acute heart failure, in light of available pathophysiological and clinical evidence. (Intern Med J 2003; 33: 515−520)

Keywords: acute heart failure; nesiritide; review; tezosentan; ­levosimendan

Document Type: Research Article


Publication date: November 1, 2003

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Partial Open Access Content
Partial Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more